UTMD - Smart Decision: Brian Koopman Acquires Utah Medical Products Stock Options | Benzinga
A noteworthy insider acquisition was disclosed on December 26, as Koopman, Principal Financial Officer at Utah Medical Products (NASDAQ:UTMD), reported the acquisition of stock options for 500 shares.
What Happened: Koopman, Principal Financial Officer at Utah Medical Products, engaged in a derivative transaction according to a Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission. This involved the acquisition of stock options for 500 shares of UTMD, providing the right to purchase the company's stock at an exercise price of $77.07 per share.
Utah Medical Products shares are trading, exhibiting down of 0.0% and priced at $85.84 during Wednesday's morning. This values Koopman's 500 shares at $4,385.
Get to Know Utah Medical Products Better
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Financial Insights: Utah Medical Products
Revenue ...